Matthew Davidson
Chairman of the BoardDr. Matthew Davidson, also known as Matt, Ph.D., has been Chairman of the Board of Azora Therapeutics, Inc. since November 3, 2026. He had been the Chief Development Officer at Adial Pharmaceuticals, Inc. since June 11, 2026 until October 28, 2026 and serves as its President and Chief Executive Officer since October 28, 2026 and also serves as its Director since June 11, 2026. He was Founder of Verrica Pharmaceuticals Inc. and served its Chief Scientific Officer from December 2017 to 2018. Dr. Davidson has biomedical research experience. His research has been published in high impact journals including The Lancet, Nature, Nature Medicine, Blood and The Journal of Immunology. From August 2013 to December 2017, Dr. Davidson served as Chief Executive Officer, President and Treasurer of Verrica Pharmaceuticals Inc. and served as its Director. He served as Member of Scientific Advisory Board at Verrica Pharmaceuticals Inc until 2020. Dr. Davidson also completed the Ignite entrepreneurship program at the Stanford Graduate School of Business in 2011. He served as the Chief Executive Officer, Co-Founder and Chairman of the Board of Directors of Azora Therapeutics, Inc. from its inception in March 2019 and also served as its Chief Financial Officer and Director. Dr. Davidson holds BA from UC Berkeley in Molecular and Cellular Biology in 2006 and his PhD in Immunology from the Stanford University School of Medicine in 2013.
Positions
- Company NameAzora Therapeutics, Inc.Stock CodeAZRPositionChairman of the Board
